# RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms

> **NCT05965739** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 328 (actual)

## Conditions studied

- Long COVID
- Long Covid19
- Long Covid-19

## Interventions

- **OTHER:** BrainHQ/Active Comparator Activity
- **OTHER:** BrainHQ
- **OTHER:** PASC CoRE
- **DEVICE:** tDCS-active
- **DEVICE:** tDCS-sham

## Key facts

- **NCT ID:** NCT05965739
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-09-19
- **Final completion:** 2024-12-17
- **Target enrollment:** 328 (ACTUAL)
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05965739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05965739, "RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT05965739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*